Multilaterale Vereinbarung M347 nach Abschnitt 1.5.1 ADR über die Beförderung des Affenpockenvirus

BUNDESGESETZBLATTFÜR DIE REPUBLIK ÖSTERREICH

Jahrgang 2022 Ausgegeben am 2. August 2022 Teil III

108. Multilaterale Vereinbarung M347 nach Abschnitt 1.5.1 ADR über die Beförderung des Affenpockenvirus

108.Multilateral Agreement M347under section 1.5.1 of ADR onthe carriage of monkeypox virus(1)Absatz einsBy derogation of Paragraph 2.2.62.1.4.1, Section 3.2.1. (Table A, Dangerous Goods List) and Chapter 4.1 of ADR, infectious substances containing monkeypox virus except for cultures of monkeypox virus may be carried under UN 3373 or UN 3291, as appropriate.(2)Absatz 2The consignor shall include the following entry in the transport document: ?Carriage in accordance with Multilateral Agreement M347?.(3)Absatz 3This agreement shall be valid until 31 December 2025 for carriage on the territories of those ADR Contracting Parties signatory to this Agreement. If it is revoked before that date by one of the signatories, it shall remain valid until the above-mentioned date only for carriage on the territories of those ADR Contracting Parties signatory to this Agreement, which have not revoked it.This agreement shall be valid until 31 December 2025 for carriage on the territories of those ADR Contracting Parties signatory to this Agreement. römisch eins f it is revoked before that date by one of the signatories, it shall remain valid until the above-mentioned date only for carriage on the territories of those ADR Contracting Parties signatory to this Agreement, which have not revoked it.(Übersetzung)Multilaterale Vereinbarung M347nach Abschnitt 1.5.1 ADRüber die Beförderung des Affenpockenvirus(1)Absatz einsAbweichend von Absatz 2.2.62.1.4.1, Abschnitt 3.2.1 (Tabelle A, Verzeichnis der gefährlichen Güter) und Kapitel 4.1 des ADR dürfen...

Um weiterzulesen

FORDERN SIE IHR PROBEABO AN

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT